Dual inhibition of tumour necrosis factor and interleukin-17A with ABT-122: Open-label long-term extension studies in rheumatoid arthritis or psoriatic arthritis
Genovese MC et al. Rheumatology (Oxford) 2018: key173. doi: 10.1093/rheumatology/key173
Please follow the link below to view this article in full on a third-party website. Note that a subscription or payment may be required.